Format

Send to

Choose Destination
Med Sci (Paris). 2019 Aug-Sep;35(8-9):651-658. doi: 10.1051/medsci/2019133. Epub 2019 Sep 18.

[Pathogenesis of thrombosis in JAK2V617F myeloproliferative neoplasms].

[Article in French; Abstract available in French from the publisher]

Author information

1
CHU de Bordeaux, Laboratoire d'hématologie, 1, avenue de Magellan, F-33600, Pessac, France. - Univ. Bordeaux, Inserm, UMR 1034, Biologie des maladies cardio-vasculaires, 1, avenue de Magellan, F-33600, Pessac, France.

Abstract

in English, French

BCR-ABL negative myeloproliferative neoplasms are acquired hematologic diseases characterized by blood cell proliferation and that include polycythemia vera (PV), essential thrombocytemia (ET) and primary myelofibrosis (PMF). Occurring of venous and arterial thrombosis is the main complication of these diseases. Risk factors for thrombosis are individuals older than 60 and history of thrombosis. The mechanisms leading to thrombosis are complex and involve several blood compartments, plasmatic factors and endothelial cells. Over the last years, new actors of thrombosis have been discovered.

PMID:
31532377
DOI:
10.1051/medsci/2019133

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center